Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-18 Purchase | 2019-11-18 4:16 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Sniecinski Megan Chief Business Officer | 45,000 | $1.45 | $65,250 | 45,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-12-15 Option Award | 2020-12-17 4:45 pm | 2021-12-15 2030-12-15 | BIOCRYST PHARMACEUTICALS INC | BCRX | Sniecinski Megan Chief Business Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2019-12-17 Option Award(A) | 2019-12-26 5:13 pm | 2020-12-17 2029-12-17 | BIOCRYST PHARMACEUTICALS INC | BCRX | Sniecinski Megan Chief Business Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2019-12-17 Option Award | 2019-12-19 5:49 pm | 2020-12-17 2029-12-17 | BIOCRYST PHARMACEUTICALS INC | BCRX | Sniecinski Megan Chief Business Officer | 202,000 | $0 | 202,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 1:25 pm | 2020-07-01 2029-07-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Sniecinski Megan Chief Business Officer | 500,000 | $0 | 500,000 (Direct) | View |